563
Views
6
CrossRef citations to date
0
Altmetric
Clinical Research

Epidemiology, toxicokinetics and biomarkers after self-poisoning with Gloriosa superba

ORCID Icon, ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 1080-1086 | Received 20 Sep 2018, Accepted 07 Feb 2019, Published online: 19 Mar 2019

References

  • Eddleston M, Persson H. Acute plant poisoning and antitoxin antibodies. J Toxicol Clin Toxicol. 2003;41:309–315.
  • Ide N, Suzuki A, Suzuki E. Case of colchicine intoxication caused by tubers of Gloriosa superba. Chudoku Kenkyu. 2010;23:243–245.
  • Kande Vidanalage CJ, Ekanayeka R, Wijewardane DK. Case report: a rare case of attempted homicide with Gloriosa superba seeds. BMC Pharmacol Toxicol. 2016;17:26.
  • Peranantham S MG, Shanmugam K. Fatal Gloriosa superba poisoning – a case report. Int J Med Pharma Sci. 2014;4:4.
  • Kavithamani D, Umadevi M, Geetha S. A review on Gloriosa superba as a medicinal plant. Ind J Res Pharma Biotech. 2013;1:4.
  • Samantha K, Kumar U. Poisoning by Glory lilly – a case report. JIAFM. 2005;27:2.
  • Fernando R, Fernando DN. Poisoning with plants and mushrooms in Sri Lanka: a retrospective hospital based study. Vet Hum Toxicol. 1990;32:579–581.
  • Rathnayaka RMMKN, Jeganadan K, Dissanayaka HDMSK, et al. Death due to poisoning with Gloriosa superba (‘Niyagala’) seeds. J Postgrad Inst Med. 2016;3:26.
  • Rathnayaka RMMKN, Ranathunga PEAN, Fernando R. Epidemiology and clinical profile of Gloriosa superba poisoning in Sri Lanka. Am J Toxicol. 2017;2:2–9.
  • Khanam PS, Sangeetha B, Kumar BV, et al. Gloriosa superba ingestion: hair loss and acute renal failure. Indian J Nephrol. 2015;25:174–176.
  • Martin P, Shiji P, Aquil K, et al. Gloriosa Superba Poisoning. Clin Proc. 2017;13:56–58.
  • Premaratna R, Weerasinghe MS, Premawardana NP, et al. Gloriosa superba poisoning mimicking an acute infection- a case report. BMC Pharmacol Toxicol. 2015;16:27.
  • Aleem HM. Gloriosa superba poisoning. J Assoc Phy India. 1992;40:541–542.
  • Peranantham S, Manigandan G, Shanmugam K. Fatal Gloriosa superba poisoning – a case report. Int J Med Pharm Sci. 2014;4:21–24.
  • Senthilkumaran S, Namasivayam B, Natrayan R, et al. Hard facts about loose stools - massive alopecia in Gloriosa superba poisoning. Int J Trichol. 2011;3:2.
  • Badwaik H, Giri TK, Tripathi DK, et al. A review on pharmacological profile for phytomedicine known as Gloriosa superba Linn. Res J Pharm Phytochem. 2011;3:5.
  • Mendis S. Colchicine cardiotoxicity following ingestion of Gloriosa superba tubers. Postgrad Med J. 1989;65:752–755.
  • Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
  • Gaiao S, Cruz DN. Baseline creatinine to define acute kidney injury: is there any consensus? Nephrol Dial Trans. 2010;25:3812–3814.
  • Mohamed F, Buckley NA, Jayamanne S, et al. Kidney damage biomarkers detect acute kidney injury but only functional markers predict mortality after paraquat ingestion. Toxicol Lett. 2015;237:140–150.
  • Wijerathna TM, Gawarammana IB, Dissanayaka DM, et al. Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid. Clin Toxicol. 2017;55:1–7.
  • Wijerathna TM, Mohamed F, Dissanayaka D, et al. Albuminuria and other renal damage biomarkers detect acute kidney injury soon after acute ingestion of oxalic acid and potassium permanganate. Toxicol Lett. 2018;299:182–190.
  • Naidus RM, Rodvien R, Mielke CH. Jr., Colchicine toxicity: a multisystem disease. Arch Intern Med. 1977;137:394–396.
  • Milne ST, Meek PD. Fatal colchicine overdose: report of a case and review of the literature. Am J Emerg Med. 1998;16:603–608.
  • Stemmermann GN, Hayashi T. Colchicine intoxication. A reappraisal of its pathology based on a study of three fatal cases. Hum Pathol. 1971;2:321–332.
  • Altman A, Szyper-Kravitz M, Shoenfeld Y. Colchicine-induced rhabdomyolysis. Clin Rheumatol. 2007;26:2197–2199.
  • Finkelstein Y, Aks SE, Hutson JR, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol. 2010;48:407–414.
  • Scherrmann JM, Boudet L, Pontikis R, et al. A sensitive radioimmunoassay for colchicine. J Pharm Pharmacol. 1980;32:800–802.
  • Rochdi M, Shah B, Pillinger MH, et al. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol. 1994;46:351–354.
  • Slobodnick A, Shah B, Pillinger MH, et al. Colchicine: old and new. Am J Med. 2015;128:461–470.
  • Sari Dogan F, Ozaydin V, Varisli B, et al. The analysis of poisoning cases presented to the emergency department within a one-year period. Turk J Emerg Med. 2014;14:160–164.
  • Mittal N, Draa ASA, Safwan Alarabi. A prospective observational study on different poisoning cases and their outcomes in a tertiary care hospital. SAGE Open Med. 2013;1:2050312113504213.
  • Elham A, Draa ASA. Safwan alarabi colchicine poisoning: a case of deliberate self poisoning, late presentation and fatal outcome. Ibnosina J Med Biomed Sci. 2015;7:4.
  • Ferron GM, Rochdi M, Jusko WJ, et al. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J Clin Pharmacol. 1996;36:874–883.
  • Thomas G, Scherrmann JM, Baud FJ. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers. Eur J Clin Pharmacol. 1989;37:79–84.
  • Borron SW, Scherrmann JM, Baud FJ. Markedly altered colchicine kinetics in a fatal intoxication: examination of contributing factors. Hum Exp Toxicol. 1996;15:885–890.
  • Wallace SL, Ertel NH. Plasma levels of colchicine after oral administration of a single dose. Metab Clin Exp. 1973;22:749–753.
  • Sabouraud A, Rochdi M, Urtizberea M, et al. Pharmacokinetics of colchicine: a review of experimental and clinical data. Z Gastroenterol. 1992;30:35–39.
  • Rudi J, Raedsch R, Gerteis C, et al. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment. Scand J Gastroenterol. 1994;29:346–351.
  • Rochdi M, Sabouraud A, Baud FJ, et al. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases. Hum Exp Toxicol. 1992;11:510–516.
  • Wallace SL, Omokoku B, Ertel NH. Colchicine plasma levels. Implications as to pharmacology and mechanism of action. Am J Med. 1970;48:443–448.
  • Imazio M, Brucato A, Trinchero R, et al. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30:532–539.
  • Folpini A, Furfori P. Colchicine toxicity–clinical features and treatment. Massive overdose case report. J Toxicol Clin Toxicol. 1995;33:71–77.
  • Huang WH, Hsu CW, Yu CC. Colchicine overdose-induced acute renal failure and electrolyte imbalance. Ren Fail. 2007;29:367–370.
  • Zeng X, Hossain D, Bostwick DG, et al. Urinary β2-microglobulin is a good indicator of proximal tubule injury: a correlative study with renal biopsies. J Biomarkers. 2014;2014:1.
  • Haase-Fielitz A, Haase M, Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem. 2014;51:335–351.
  • Mohamed F, Endre ZH, Buckley NA. Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countries. Br J Clin Pharmacol. 2015;80:3–19.
  • Mohamed F, Endre ZH, Pickering JW, et al. Mechanism-specific injury biomarkers predict nephrotoxicity early following glyphosate surfactant herbicide (GPSH) poisoning. Toxicol Lett. 2016;258:1–10.
  • Yu Y, Jin H, Holder D, et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotechnol. 2010;28:470–477.
  • Zurek J, Kyr M, Vavrina M, et al. Trefoil factor 3 as a marker of intestinal cell damage during sepsis. Open Med (Wars). 2015;10:261–266.
  • Vestergaard EM, Poulsen SS, Grønbaek H, et al. Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem. 2002;48:1689–1695.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.